Researchers develop structural blueprint of nanoparticles to target white blood cells responsible for acute lung inflammation

A potential new route to the diagnosis and treatment of ARDS comes from studying how neutrophils -- the white blood cells responsible for detecting and eliminating harmful particles in the body -- differentiate what materials to uptake by the material's surface structure, and favor uptake of particles that exhibit 'protein clumping,' according to new research.